Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 12 of 35

COMPLETED NA

Effectiveness of Interactive Voice Response for COVID-19 Vaccination Training in the Democratic Republic of the Congo

NCT05107479

COMPLETED

Stanford Regulating Circuits of the Brain Study - MDMA

NCT04060108

COMPLETED Phase 1

Evaluating the Benefits of Physiologic Insulin Delivery

NCT04416737

COMPLETED

Evaluation of Inpatient Sleep and Activity Following Childbirth

NCT05065203

COMPLETED NA

Stanford Tobacco Treatment Services - Virtual Reality Treatment for Smoking Cessation

NCT05220254

TERMINATED NA

Zemedy Application for Irritable Bowel Syndrome

NCT04723056

COMPLETED NA

Mobile Strategy to Reduce the Risk of Recurrent Preterm Birth

NCT04663607

COMPLETED NA

Feasibility of Teleyoga for Treatment of Lyme Disease

NCT04867473

TERMINATED Phase 1

18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma

NCT05096234

COMPLETED NA

Virtual Empowered Relief for Chronic Pain

NCT05057988

COMPLETED NA

Effects of Mindfulness Training on Burnout and Mood in Hospital Employees

NCT04307563

COMPLETED

Game-based Telehealth Therapeutic Intervention in First Onset Psychosis

NCT04799717

COMPLETED NA

Patient-Reported Outcome Measurement in Heart Failure Clinic

NCT04164004

COMPLETED NA

Social Factors in the Mental Health of Young Adults: Bridging Psychological and Network Analysis

NCT04771195

COMPLETED Early Phase 1

Online "Pain, Stress & Emotions" Class in Chronic Pain

NCT05014126

TERMINATED NA

Suture-based, Minimally Invasive Technique Used to Correct NSD

NCT04891263

COMPLETED Phase 1

Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis

NCT04669158

COMPLETED

Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events

NCT05123001

COMPLETED NA

A Lead-in Study Evaluating Efficacy of GuessWhat Mobile App Therapy for Children With Autism

NCT04739982

COMPLETED Phase 2

Oxidative Stress and Surgical Recovery

NCT04732000

COMPLETED Phase 1

Vitamin D Regulation of Gut Specific B Cells and Antibodies Targeting Gut Bacteria in Inflammatory Bowel Disease

NCT04828031

TERMINATED NA

Pain Catastrophizing and Prescription Opioid Craving

NCT04097743

COMPLETED NA

Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction

NCT04406584

COMPLETED Phase 2

Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma

NCT04710498

COMPLETED Phase 4

Effect of Tranexamic Acid on Postoperative Bleeding Following Sinus and Nasal Surgery

NCT04754230

COMPLETED NA

Early Percutaneous Cryoablation for Pain Control After Rib Fractures Among Elderly Patients

NCT04482582

COMPLETED NA

A Novel Use of a Sleep Intervention to Target the Emotion Regulation Brain Network to Treat Depression and Anxiety

NCT04424407

COMPLETED NA

Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling

NCT05132868

COMPLETED Phase 1

Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

NCT04474353

TERMINATED Early Phase 1

Gastrointestinal STRING Test With Oral Immunotherapy

NCT04943744

COMPLETED NA

Esophageal Atresia: a Natural Experiment of the Effects of Oral Inoculation on the Gut Microbiome

NCT04901546

COMPLETED

Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults With Neurofibromatosis Type 1

NCT04941027

COMPLETED NA

Gardner Packard Healthy Lifestyles Program

NCT05107648

COMPLETED NA

Community Health Workers and Precision Medicine

NCT04843332

COMPLETED NA

Neural Mechanisms of Successful Intervention in Children With Dyslexia

NCT04323488

TERMINATED NA

Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts

NCT04534010

COMPLETED NA

SWAP-MEAT Athlete: Three Diets on Athletic Performance

NCT05472701

COMPLETED Phase 2

COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol

NCT04662060

COMPLETED Phase 2

COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol

NCT04662086

TERMINATED Phase 2

COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol

NCT04662073

COMPLETED Phase 2

Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Loss

NCT04701333

TERMINATED NA

Remote Monitoring of Respiratory Health

NCT04739943

COMPLETED NA

Mobile Technology for Blood Pressure Management

NCT04841317

COMPLETED

Understanding Immunity to the COVID-19 Vaccines

NCT04664309

COMPLETED NA

Managing Insulin With a Voice AI

NCT05081011

COMPLETED NA

Mental Health Disparities in Spanish Speaking Latina Breast Cancer Patients

NCT04834154

TERMINATED

Cerebral Blood Flow Evaluation With Trancranial Doppler After Interscalene Nerve Block

NCT04642612

COMPLETED

Peripheral Immune System in Individuals With Schizophrenia

NCT05109065

COMPLETED NA

BRAVE: Building Resilience and Values Through E-health

NCT05227599

COMPLETED NA

Testing of a Tool to Elicit Patient Preferences for CTS

NCT03532373

← Previous Page 12 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.